Metabolomic profiling refines cardiovascular risk stratification beyond SCORE2-diabetes in patients with concurrent type 2 diabetes and pulmonary dysfunction
Frontiers in Endocrinology
- Machine learning
- Lipid and ceramide metabolism
- SCORE2-Diabetes
- Type 2 diabetes
- Lung function impairment
- Humans
The paper
Li M, Shen Y, Huang Y et al.
Frontiers in Endocrinology · 26 Aug 2026

